REQUEST A DEMO
Total
USD $0.00
Search more companies

Neuroimport S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Health and Personal Care Stores | Pharmacies and Drug Stores
Full name: Neuroimport S.A.S. Profile Updated: September 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Neuroimport S.A.S. is an enterprise in Ecuador, with the main office in Guayaquil. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on May 21, 2021. The total number of employees is currently 2 (2024). There was a net sales revenue drop of 18.13% reported in Neuroimport S.A.S.’s latest financial highlights for 2025. Over the same period, its total assets grew by 23.83%. The enterprise’s net profit margin decreased by 7.69% in 2025.

Headquarters
Calle C.12A
Guayaquil; Guayas;

Contact Details: Purchase the Neuroimport S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Neuroimport S.A.S. report to view the information.
Registered Capital:
Purchase the Neuroimport S.A.S. report to view the information.
Financial Auditors:
Purchase the Neuroimport S.A.S. report to view the information.
Incorporation Date:
May 21, 2021
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Neuroimport S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-18.13%
Total Operating Revenue
-18.13%
Operating Profit
-9.32%
EBITDA
-8.15%
Net Profit/Loss for the Period
-29.54%
Total Assets
23.83%
Total Equity
-15.08%
Operating Profit Margin
5.96%
Net Profit Margin
-7.69%
Return on Equity (ROE)
-16.45%
Debt / Equity
18.88%
Quick Ratio
-1.55%
Cash Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?